Your browser doesn't support javascript.
loading
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma.
Driessen, Christoph; Müller, Rouven; Novak, Urban; Cantoni, Nathan; Betticher, Daniel; Mach, Nicolas; Rüfer, Axel; Mey, Ulrich; Samaras, Panagiotis; Ribi, Karin; Besse, Lenka; Besse, Andrej; Berset, Catherine; Rondeau, Stephanie; Hawle, Hanne; Hitz, Felicitas; Pabst, Thomas; Zander, Thilo.
Afiliação
  • Driessen C; Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Müller R; Department of Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Novak U; Department of Medical Oncology, Inselspital, Universitätsspital Bern, Bern, Switzerland.
  • Cantoni N; Division of Hematology, Kantonsspital Aarau AG, Aarau, Switzerland.
  • Betticher D; Division of Oncology and Hematology, HFR Fribourg, Fribourg, Switzerland.
  • Mach N; University Hospital Geneva, Geneva, Switzerland.
  • Rüfer A; Division of Hematology, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Mey U; Kantonsspital Graubünden, Chur, Switzerland.
  • Samaras P; Universitaetsspital Zurich, Zurich, Switzerland.
  • Ribi K; Coordinating Center, International Breast Cancer Study Group, Bern, Switzerland.
  • Besse L; Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Besse A; Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Berset C; Coordinating Center, Swiss Group for Clinical Cancer Research, Bern, Switzerland; and.
  • Rondeau S; Coordinating Center, Swiss Group for Clinical Cancer Research, Bern, Switzerland; and.
  • Hawle H; Coordinating Center, Swiss Group for Clinical Cancer Research, Bern, Switzerland; and.
  • Hitz F; Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Pabst T; Department of Medical Oncology, Inselspital, Universitätsspital Bern, Bern, Switzerland.
  • Zander T; Department of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland.
Blood ; 132(19): 2097-2100, 2018 11 08.
Article em En | MEDLINE | ID: mdl-30237154
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Nelfinavir / Inibidores de Proteassoma / Bortezomib / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Nelfinavir / Inibidores de Proteassoma / Bortezomib / Mieloma Múltiplo / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça